Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 102

1.

Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.

Ricken R, Adli M, Lange C, Krusche E, Stamm TJ, Gaus S, Koehler S, Nase S, Bschor T, Richter C, Steinacher B, Heinz A, Rapp MA, Borgwardt S, Hellweg R, Lang UE.

J Clin Psychopharmacol. 2013 Dec;33(6):806-9. doi: 10.1097/JCP.0b013e3182a412b8.

PMID:
24018547
[PubMed - indexed for MEDLINE]
2.

Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial.

Cipriani A, Girlanda F, Agrimi E, Barichello A, Beneduce R, Bighelli I, Bisoffi G, Bisogno A, Bortolaso P, Boso M, Calandra C, Cascone L, Corbascio C, Parise VF, Gardellin F, Gennaro D, Hanife B, Lintas C, Lorusso M, Luchetta C, Lucii C, Cernuto F, Tozzi F, Marsilio A, Maio F, Mattei C, Moretti D, Appino MG, Nosè M, Occhionero G, Papanti D, Pecile D, Purgato M, Prestia D, Restaino F, Sciarma T, Ruberto A, Strizzolo S, Tamborini S, Todarello O, Ziero S, Zotos S, Barbui C.

BMC Psychiatry. 2013 Aug 13;13:212. doi: 10.1186/1471-244X-13-212.

PMID:
23941474
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Extended-release quetiapine fumarate (quetiapine XR) monotherapy and quetiapine XR or lithium as add-on to antidepressants in patients with treatment-resistant major depressive disorder.

Bauer M, Dell'osso L, Kasper S, Pitchot W, Dencker Vansvik E, Köhler J, Jørgensen L, Montgomery SA.

J Affect Disord. 2013 Oct;151(1):209-19. doi: 10.1016/j.jad.2013.05.079. Epub 2013 Jun 27.

PMID:
23810357
[PubMed - indexed for MEDLINE]
4.

[Augmentation of antidepressants with unsaturated fatty acids omega-3 in drug-resistant depression].

Krawczyk K, Rybakowski J.

Psychiatr Pol. 2012 Jul-Aug;46(4):585-98. Polish.

PMID:
23214161
[PubMed - indexed for MEDLINE]
5.

Comparing augmentation with non-antidepressants over sticking to antidepressants after treatment failure in depression: a naturalistic study.

Köhler S, Unger T, Hoffmann S, Steinacher B, Fydrich T, Bschor T.

Pharmacopsychiatry. 2013 Mar;46(2):69-76. doi: 10.1055/s-0032-1323677. Epub 2012 Oct 23.

PMID:
23093475
[PubMed - indexed for MEDLINE]
6.

Prediction of longer-term outcome of treatment-resistant depression in tertiary care.

Fekadu A, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Cleare AJ.

Br J Psychiatry. 2012 Nov;201(5):369-75. doi: 10.1192/bjp.bp.111.102665. Epub 2012 Sep 6.

PMID:
22955008
[PubMed - indexed for MEDLINE]
Free Article
7.

Walking on thin ice: the use of triple antidepressant combinations in refractory melancholic depression.

Restifo S.

Australas Psychiatry. 2012 Apr;20(2):134-7. doi: 10.1177/1039856212436434. Epub 2012 Mar 30.

PMID:
22467559
[PubMed - indexed for MEDLINE]
8.

Bipolarity and inadequate response to antidepressant drugs: clinical and psychopharmacological perspective.

Rybakowski JK.

J Affect Disord. 2012 Jan;136(1-2):e13-9. doi: 10.1016/j.jad.2011.05.005. Epub 2011 May 31. Review.

PMID:
21621266
[PubMed - indexed for MEDLINE]
9.

Prospective evaluation of specialist inpatient treatment for refractory affective disorders.

Wooderson SC, Juruena MF, Fekadu A, Commane C, Donaldson C, Cowan M, Tomlinson M, Poon L, Markopoulou K, Rane L, Donocik J, Tunnard C, Masterson B, Cleare AJ.

J Affect Disord. 2011 Jun;131(1-3):92-103. doi: 10.1016/j.jad.2010.11.002. Epub 2010 Dec 7.

PMID:
21144591
[PubMed - indexed for MEDLINE]
10.

Long-term naturalistic follow-up of lithium augmentation: relevance to bipolarity.

Inoue T, Abekawa T, Nakagawa S, Suzuki K, Tanaka T, Kitaichi Y, Boku S, Nakato Y, Toda H, Koyama T.

J Affect Disord. 2011 Mar;129(1-3):64-7. doi: 10.1016/j.jad.2010.08.022. Epub 2010 Sep 16.

PMID:
20837361
[PubMed - indexed for MEDLINE]
11.

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression.

Diazgranados N, Ibrahim L, Brutsche NE, Newberg A, Kronstein P, Khalife S, Kammerer WA, Quezado Z, Luckenbaugh DA, Salvadore G, Machado-Vieira R, Manji HK, Zarate CA Jr.

Arch Gen Psychiatry. 2010 Aug;67(8):793-802. doi: 10.1001/archgenpsychiatry.2010.90.

PMID:
20679587
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Predictors of efficacy in lithium augmentation for treatment-resistant depression.

Sugawara H, Sakamoto K, Harada T, Ishigooka J.

J Affect Disord. 2010 Sep;125(1-3):165-8. doi: 10.1016/j.jad.2009.12.025. Epub 2010 Jan 20.

PMID:
20089312
[PubMed - indexed for MEDLINE]
13.

Lamotrigine versus lithium augmentation of antidepressant therapy in treatment-resistant depression: efficacy and tolerability.

Ivković M, Damjanović A, Jovanović A, Cvetić T, Jasović-Gasić M.

Psychiatr Danub. 2009 Jun;21(2):187-93.

PMID:
19556947
[PubMed - indexed for MEDLINE]
Free Article
14.

Cortical folding in patients with bipolar disorder or unipolar depression.

Penttilä J, Paillère-Martinot ML, Martinot JL, Ringuenet D, Wessa M, Houenou J, Gallarda T, Bellivier F, Galinowski A, Bruguière P, Pinabel F, Leboyer M, Olié JP, Duchesnay E, Artiges E, Mangin JF, Cachia A.

J Psychiatry Neurosci. 2009 Mar;34(2):127-35.

PMID:
19270763
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Attitudes of old age psychiatrists in England and Wales to the use of mood stabilizer drugs.

Ephraim E, Prettyman R.

Int Psychogeriatr. 2009 Jun;21(3):576-80. doi: 10.1017/S1041610209008667. Epub 2009 Mar 4.

PMID:
19257918
[PubMed - indexed for MEDLINE]
16.

Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE).

Rasmussen KG, Mueller M, Rummans TA, Husain MM, Petrides G, Knapp RG, Fink M, Sampson SM, Bailine SH, Kellner CH.

J Clin Psychiatry. 2009 Feb;70(2):232-7. Epub 2009 Jan 13.

PMID:
19192459
[PubMed - indexed for MEDLINE]
17.

Is there a place for tricyclic antidepressants and subsequent augmentation strategies in obtaining remission for patients with treatment resistant depression?

Gervasoni N, Aubry JM, Gex-Fabry M, Bertschy G, Bondolfi G.

Pharmacol Res. 2009 Mar;59(3):202-6. doi: 10.1016/j.phrs.2008.11.005. Epub 2008 Nov 27.

PMID:
19073260
[PubMed - indexed for MEDLINE]
18.

Anxious depression and the stiff-person plus syndrome.

Culav-Sumić J, Bosnjak I, Pastar Z, Jukić V.

Cogn Behav Neurol. 2008 Dec;21(4):242-5. doi: 10.1097/WNN.0b013e318185e6d2.

PMID:
19057174
[PubMed - indexed for MEDLINE]
19.

Outcome of late-life depression after 3 years of sequential treatment.

Kok RM, Nolen WA, Heeren TJ.

Acta Psychiatr Scand. 2009 Apr;119(4):274-81. doi: 10.1111/j.1600-0447.2008.01295.x. Epub 2008 Nov 24.

PMID:
19053970
[PubMed - indexed for MEDLINE]
20.

Lithium augmentation compared with phenelzine in treatment-resistant depression in the elderly: an open, randomized, controlled trial.

Kok RM, Vink D, Heeren TJ, Nolen WA.

J Clin Psychiatry. 2007 Aug;68(8):1177-85.

PMID:
17854241
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk